LPIN2 antisense RNA 1 (LPIN2-AS1)

LPIN2 antisense RNA 1 (LPIN2-AS1) is a predicted long non-coding RNA gene transcribed from the opposite strand of the LPIN2 locus and is classified as an antisense lncRNA. Antisense lncRNAs, including LPIN2-AS1, generally regulate the expression of their corresponding sense genes through mechanisms involving RNA-RNA interactions, modulation of chromatin architecture, or influence on transcriptional and post-transcriptional gene regulation[6][7][8]. There is currently no direct evidence that LPIN2-AS1 is a therapeutic target, nor is there a documented role in human disease or known interactions with drugs. Most available information and disease association pertains to LPIN2 (lipin-2), not to the antisense transcript LPIN2-AS1[5][9]. No common aliases or alternative names are documented. No recognized safety concerns, biomarkers, or mechanisms of drug interaction have been established for this molecule. **Note:** There is an incomplete knowledge base about the specific functions of LPIN2-AS1 as an individual RNA. The molecule should not be confused with the protein-coding gene LPIN2, which is implicated in autoinflammatory disorders[1][9]. This entry is flagged as "is_incorrect: true" because LPIN2-AS1 is not a known drug target, receptor, or enzyme, and there is insufficient functional annotation or disease relevance in current biomedical literature.